Industry News
ARIAD reaches 50 percent patient enrollment in Phase 3 EPIC trial of Iclusig
Sep 06, 2013
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) has announced enrollment of fifty percent of the patients planned in its randomized Phase 3 trial of Iclusig® (ponatinib) in adult patients with newly diagnosed chronic myeloid leukemia (CML)... Read More
Publication demonstrates superior activity of ISA Pharmaceuticals' SLP® vaccines compared to whole protein vaccines
Sep 06, 2013
ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company focusing on rationally designed therapeutic vaccines against cancer and persistent viral infections, has announced the publication of a peer-reviewed paper in the European Journal of Immunology... Read More
Chemotherapy helps elderly patients with small cell lung cancer
Sep 06, 2013
Although numerous randomized clinical trials have demonstrated a benefit of chemotherapy for patients with small-cell lung cancer (SCLC), these trials have predominantly compared different chemotherapy regimens rather than comparing chemotherapy to best supportive care. Some of them included chest radiation or prophylactic cranial irradiation. Moreover, many trials excluded elderly patients... Read More
No racial difference for survival in African American versus Caucasian lung cancer patients
Sep 06, 2013
According to the American Cancer Society, an estimated 160,340 lung cancer deaths occurred in the United States in 2012, accounting for 28 percent of all cancer deaths. While survival from lung cancer has improved since the early 1990s, racial differences in lung cancer survival persist such that blacks experience poorer 5-year survival for lung cancer compared to whites... Read More
Scientists link a protein to initial tumor growth in several cancers
Sep 06, 2013
A team led by scientists from The Scripps Research Institute (TSRI) have shown that a protein once thought to inhibit the growth of tumors is instead required for initial tumor growth. The findings could point to a new approach to cancer treatment. The study was published this week as the cover article of the journal Science Signaling... Read More
Brain surgery could improve with laser-guided tool
Sep 06, 2013
A new type of laser microscope may dramatically improve the accuracy of brain tumor surgery, according to a study reported this week in Science Translational Medicine. The new tool helps surgeons see clearly, while operating, where tumor tissue ends and healthy tissue begins... Read More
New pathway in blood vessel inflammation and disease discovered - Kruppel-like factors as master regulators of vascular health
Sep 06, 2013
Case Western Reserve researchers have identified a genetic factor that blocks the blood vessel inflammation that can lead to heart attacks, strokes and other potentially life-threatening events. The breakthrough involving Kruppel-like factor (KLF) 15 is the latest in a string of discoveries from the laboratory of professor of medicine Mukesh K... Read More
Blind mole-rats are resistant to chemically induced cancers
Sep 06, 2013
Like naked mole-rats (Heterocephalus gaber), blind mole-rats (of the genus Spalax) live underground in low-oxygen environments, are long-lived and resistant to cancer. A new study demonstrates just how cancer-resistant Spalax are, and suggests that the adaptations that help these rodents survive in low-oxygen environments also play a role in their longevity and cancer resistance... Read More
Head, neck cancer care being concentrated at teaching hospitals, academic centers
Sep 05, 2013
Head and neck cancer care is being concentrated at teaching hospitals and academic medical centers, according to a study by Elliot Abemayor, M.D., Ph.D., of the David Geffen School of Medicine at the University of California, Los Angeles, and colleagues... Read More
New ovarian cancer gene found in mice
Sep 05, 2013
Cancer Research UK scientists have discovered a gene that repairs damaged DNA is also linked to ovarian cancer in mice. They say if the gene - known as Helq - is faulty or missing, DNA errors accumulate as cells multiply, and this raises the chance of developing the cancer. They write about their findings in the September 4th online issue of Nature... Read More
Previous Page Next Page